Alzheimer’s disease (AD) is a debilitating neurodegenerative disease hallmarked by the presence of amyloid-β (Aβ) plaques and tau fibrils but with limited treatment options. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.